1. Pathogenesis of refractory hyperparathyroidism;Rodriguez;Kidney Int,2002
2. Management of secondary hyperparathyroidism;Moe;The importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product,2003
3. Control of uremic bone disease;Slatopolsky;Role of vitamin D analogs,2002
4. Receptor activator selectivity in the treatment of secondary hyperparathyroidism;Brancaccio;Understanding the differences among therapies,2007
5. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy;Goodman;Kidney Int,1994